Recombitek Canine Parvo (Canada)

Parvovirus Vaccine

Modified Live Virus

CPV

DESCRIPTION: RECOMBITEK^® Canine Parvo contains canine parvovirus, propagated in a stable cell line. Safety and efficacy of this product have been demonstrated by vaccination and challenge tests.

INDICATIONS: RECOMBITEK^® Canine Parvo is recommended for the vaccination of healthy dogs 6 weeks of age and older for prevention of disease due to canine parvovirus.

DOSAGE: Aseptically inject 1 mL (1 dose) subcutaneously or intramuscularly into healthy dogs. For primary vaccination, revaccinate with a second 1 mL dose 2 to 3 weeks later. Dogs younger than 12 weeks of age should be revaccinated with a single 1 mL dose every 2 to 3 weeks, the last dose given at or over 12 weeks of age. Revaccinate annually with a single 1 mL dose.

PRECAUTIONS: Store at 2-7°C (35-45°F). Do not use chemicals to sterilize syringes and needles. Burn container and all unused contents. Contains gentamicin and thimerosal as preservatives. It is generally recommended to avoid vaccination of pregnant dogs. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine.

SOLD TO VETERINARIANS ONLY.

For Veterinary Use Only.

RECOMBITEK is a registered trademark of MERIAL.

Manufactured By MERIAL INC., Athens, GA 30601 USA

U.S. Vet. Lic. No. 298

1-888-Merial-1 (1-888-637-4251)

Distributed In Canada By MERIAL CANADA, INC., Baie d’Urfé, Qc, H9X 3V1, Canada

CPN: 1182008.4